MedPath

ERWINASE

ERWINASE

Discontinued
DIN Number

02237815

Drug Class

Human

Market Date

Jul 1, 2009

Company
HC

jazz pharmaceuticals france sas

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02237815
AIG Number0109328001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L01XX02 ASPARAGINASE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntramuscular ,  Subcutaneous ,  Intravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ASPARAGINASEActive
Strength: 10000 UNIT / VIAL
Monograph: ASPARAGINASE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.